(Q38949921)

7 September 2017

1 reference

title

Host factors in the pathogenesis of HIV disease (English)

1 reference

7 September 2017

3

Fauci AS

1 reference

7 September 2017

Cohen OJ

1

1 reference

7 September 2017

Kinter A

series ordinal

2

1 reference

7 September 2017

publication date

1 October 1997

1 reference

7 September 2017

published in

Immunological Reviews

1 reference

7 September 2017

volume

159

1 reference

7 September 2017

page(s)

31-48

1 reference

Host factors and the pathogenesis of HIV-induced disease

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Expression cloning of new receptors used by simian and human immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Intestinal mucosal inflammation associated with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Interleukin-12 and its role in the generation of TH1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Cytokine modulation of HIV expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

IL4 and IL10 as potent inhibitors of HIV1 replication in macrophages in vitro: a role for cytokines in the in vivo virus host range?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

IL-10 inhibits HIV-1 replication and is induced by tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Th2-mediated HIV1 virostatic state: macrophage-specific regulation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Human chemokines: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Chemokines, leukocyte trafficking, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Immune activation is a dominant factor in the pathogenesis of African AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Accelerated course of human immunodeficiency virus infection after tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Activation of virus replication after vaccination of HIV-1-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Long-Term Human Immunodeficiency Virus Infection in Asymptomatic Homosexual and Bisexual Men with Normal CD4+ Lymphocyte Counts: Immunologic and Virologic Characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Cytotoxic T cells--protection from disease progression--protection from infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV suppression by interleukin-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Long-term symptomless HIV-1 infection in recipients of blood products from a single donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV-1 infection in a man homozygous for CCR5▵32

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV-1 subtype and second-receptor use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Interleukin-13: characterization and biologic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

The role of interleukin 12 in the immune response, disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Macrophages as a source of HIV during opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

HIV-1 infection in an individual homozygous for the CCR5 deletion allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01005.X

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.3313729

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.270.5243.1811

Identifiers

DOI

10.1111/J.1600-065X.1997.TB01005.X

1 reference

7 September 2017

1 reference